DBD Valuation

Diebold Nixdorf Inc

Add to Watchlist

Advanced Chart

61.360

+0.68(1.121%)1D

Overview
Forecast
Valuation
Earnings

DBD Relative Valuation

DBD's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, DBD is overvalued; if below, it's undervalued.

Historical Valuation

Diebold Nixdorf Inc (DBD) is now in the Undervalued zone, suggesting that its current forward PE ratio of 13.86 is considered Undervalued compared with the five-year average of 8.65. The fair price of Diebold Nixdorf Inc (DBD) is between 91.36 to 109.74 according to relative valuation methord. Compared to the current price of 60.56 USD , Diebold Nixdorf Inc is Undervalued By 33.71%.

Relative Value

Fair Zone

91.36-109.74

Current Price：60.56

33.71%

Undervalued

13.91

Trailing

Forward

5.71

EV/EBITDA

Diebold Nixdorf Inc. (DBD) has a current EV/EBITDA of 5.71. The 5-year average EV/EBITDA is 4.99. The thresholds are as follows: Strongly Undervalued below 3.71, Undervalued between 3.71 and 4.35, Fairly Valued between 5.63 and 4.35, Overvalued between 5.63 and 6.27, and Strongly Overvalued above 6.27. The current Forward EV/EBITDA of 5.71 falls within the Overvalued range.

8.46

EV/EBIT

Diebold Nixdorf Inc. (DBD) has a current EV/EBIT of 8.46. The 5-year average EV/EBIT is 6.10. The thresholds are as follows: Strongly Undervalued below 3.66, Undervalued between 3.66 and 4.88, Fairly Valued between 7.32 and 4.88, Overvalued between 7.32 and 8.54, and Strongly Overvalued above 8.54. The current Forward EV/EBIT of 8.46 falls within the Overvalued range.

0.57

Diebold Nixdorf Inc. (DBD) has a current PS of 0.57. The 5-year average PS is 0.38. The thresholds are as follows: Strongly Undervalued below 0.17, Undervalued between 0.17 and 0.28, Fairly Valued between 0.48 and 0.28, Overvalued between 0.48 and 0.59, and Strongly Overvalued above 0.59. The current Forward PS of 0.57 falls within the Overvalued range.

8.84

P/OCF

Diebold Nixdorf Inc. (DBD) has a current P/OCF of 8.84. The 5-year average P/OCF is 6.81. The thresholds are as follows: Strongly Undervalued below 3.06, Undervalued between 3.06 and 4.94, Fairly Valued between 8.69 and 4.94, Overvalued between 8.69 and 10.56, and Strongly Overvalued above 10.56. The current Forward P/OCF of 8.84 falls within the Overvalued range.

10.02

P/FCF

Diebold Nixdorf Inc. (DBD) has a current P/FCF of 10.02. The 5-year average P/FCF is 9.80. The thresholds are as follows: Strongly Undervalued below 6.58, Undervalued between 6.58 and 8.19, Fairly Valued between 11.41 and 8.19, Overvalued between 11.41 and 13.02, and Strongly Overvalued above 13.02. The current Forward P/FCF of 10.02 falls within the Historic Trend Line -Fairly Valued range.

Diebold Nixdorf Inc (DBD) has a current Price-to-Book (P/B) ratio of 2.03. Compared to its 3-year average P/B ratio of 1.33 , the current P/B ratio is approximately 52.36% higher. Relative to its 5-year average P/B ratio of 1.33, the current P/B ratio is about 52.36% higher. Diebold Nixdorf Inc (DBD) has a Forward Free Cash Flow (FCF) yield of approximately 9.01%. Compared to its 3-year average FCF yield of -10.97%, the current FCF yield is approximately -182.14% lower. Relative to its 5-year average FCF yield of -10.97% , the current FCF yield is about -182.14% lower.

2.04

P/B

Median3y

1.33

Median5y

1.33

9.07

FCF Yield

Median3y

-10.97

Median5y

-10.97

Competitors Valuation Multiple

The average P/S ratio for DBD's competitors is 3.28, providing a benchmark for relative valuation. Diebold Nixdorf Inc Corp (DBD) exhibits a P/S ratio of 0.57, which is -82.76% above the industry average. Given its robust revenue growth of -2.61%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Standex International Corp

Evolv Technologies Holdings Inc

Performance Decomposition

Market capitalization of DBD increased by 36.90% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -114.62 to -173.04.

The secondary factor is the Revenue Growth, contributed -2.61%to the performance.

Overall, the performance of DBD in the past 1 year is driven by P/E Change. Which is more unsustainable.

-2.61%

939.70M → 915.20M

Revenue Growth

-11.46%

1.57 → 1.39

Margin Expansion

50.97%

-114.62 → -173.04

P/E Change

36.90%